Skip to main content

Companies researching Lynparza (Olaparib)

Lynparza (olaparib) is a PARP‑inhibitor medication used as maintenance therapy for adults with advanced ovarian cancer that carries a BRCA mutation.

List of companies that research Lynparza (Olaparib)

This is sourced from job postings — companies only hire for what they actively use or plan to adopt · how we source this →

  • AstraZeneca logo
    United KingdomEmployees77kPharmaceutical Manufacturing
    Lynparza (Olaparib)Low confidence
  • The Institute of Cancer Research logo
    United KingdomEmployees1.6kRevenue$35MResearch Services
    Lynparza (Olaparib)Low confidence
  • The University of Sheffield logo
    United KingdomEmployees11kRevenue$716MHigher Education
    Lynparza (Olaparib)Low confidence
  • MSD logo
    United StatesEmployees40kRevenue$10BPharmaceutical Manufacturing
    Lynparza (Olaparib)Low confidence

Showing top companies out of 12 that research Lynparza (Olaparib). Get the full list on TheirStack.

Frequently asked questions